StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
PBH

Prestige Consumer Healthcare Inc.

PBH NYSE Pharmaceutical Preparations EDGAR ↗
$51.92
+1.97 +3.94%

Key statistics

from XBRL data in SEC filings
Market cap
$2.46B
Revenue (TTM)
$1.09B
Net income (TTM)
$190M
EPS (TTM)
$3.91
P/E ratio
13.3
Dividend yield
Free cash flow
$246M
Cash
$63.9M
Total assets
$3.49B
Gross margin
54.7%
52-week range
$42.62 – $75.31

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement; Took on a direct financial obligation Jul 15, 2026 8-K/A Jul 9, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Jul 6, 2026 8-K/A Jun 30, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Other events Jun 16, 2026 10-K Fiscal year ended 2026-03-31 May 14, 2026 8-K Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure May 13, 2026 8-K Entered a material agreement; Regulation FD disclosure; Other events Mar 20, 2026 10-Q Quarter ended 2025-12-31 Feb 5, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 5, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure Aug 7, 2025 10-K Fiscal year ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 8, 2025 10-Q Quarter ended 2024-12-31 Feb 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 6, 2025 8-K Director or officer change Jan 6, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 8, 2024 10-K Fiscal year ended 2024-03-31 May 15, 2024 8-K Results of operations (earnings release); Regulation FD disclosure; Other events May 14, 2024 8-K Director or officer change May 8, 2024 10-Q Quarter ended 2023-12-31 Feb 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Feb 8, 2024 8-K Entered a material agreement; Took on a direct financial obligation Dec 13, 2023 10-Q Quarter ended 2023-09-30 Nov 2, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Nov 2, 2023 10-Q Quarter ended 2023-06-30 Aug 3, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Aug 3, 2023 10-K Fiscal year ended 2023-03-31 May 5, 2023 8-K Results of operations (earnings release); Regulation FD disclosure; Other events May 4, 2023 10-Q Quarter ended 2022-12-31 Feb 2, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Feb 2, 2023 10-Q Quarter ended 2022-09-30 Nov 3, 2022 8-K Results of operations (earnings release); Regulation FD disclosure Nov 3, 2022 10-Q Quarter ended 2022-06-30 Aug 4, 2022